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Introduction 
The moment of the COVID-19 pandemic has 
brought to the world the need to find forms of treatment 
and of prophylaxis to face the disease caused by the 
virus [1]. Among so many alternatives, an April 2020 
study has shown to be promising in proposing the use 
of the drug Ivermectin, which in an in vitro study, 
presented a reduction in the amount of viral RNA, 
suggesting the possibility of efficacy in the treatment 
and in the prophylaxis of COVID-19. Nevertheless, the 
studies have not advanced from the in vitro phase [2].  
This drug, approved by Anvisa, is a broad-
spectrum antiparasitic used clinically for onchocerciasis 
and lymphatic filariasis control in single doses of 150 to 
200μg/kg. It has an excellent safety profile and, after 
oral administration, the plasma concentrations are, 
approximately, dose proportional. Therefore, the 
Ivermectin presents itself as a very fruitful drug and 
deserves a further research into possible human 
benefits, mainly due to the scarce drug interaction, 
which facilitates the treatment of people infected with 
Covid-19, if the administration of other drugs is needed 
concomitantly [3].  
This study aims to analyze whether the population 
used Ivermectin prophylactically against Covid-19 with 
or without a guidance of a health professional and 
compare information sources for drug use. 
 
Methods 
Between October 2020 and February 2021 a link 
was shared (https://forms.gle/NPW3yfZLPRggVioV9) 
containing a questionnaire prepared by the research 
team on questions related to the prophylactic Ivermectin 
use, as well as socio-demographic data and the media 
investigation used by the population. The questionnaire 
was disseminated through the researchers' social 
networks and was available for two months. The 
participants had access to the TCLE so that they had 
knowledge about the study and, if they were over 18, 
they could answer the questionnaire. After the specified 
period, the questionnaire was blocked, the answers 
were tabulated and statistically analyzed. 
 
Ethical Approval 
This study was approved by the CEP/CONEP 
Research Ethics Committee in accordance with CNS 
resolution nº 466/12 under registration nº 4.312.261. 
 
Results and Discussion 
The Covid-19 pandemic has generated a major 
public health problem, especially for leading the 
population to make indiscriminate use of medicines 
because they glimpse the promise of prophylaxis against 
the pathology, however, without scientific evidence for 
this. This study evaluated 455 participants, most 
between 18 and 29 years old (n=170, 37,4%), of female 
sex (n=333, 73,2%), with higher education (Table 1) 
and determined that health professionals and students 
are more informed through scientific articles when 
compared to other professions (Table 2). 
Health professions are always questionaded about 
the pandemic, therefore, it is of utmost importance that 
they update themselves correctly. The findings of this 
study show that most of these professionals get 
informed on Official Health Sites (36,5%) and on 
Scientific Publications (51,9%) and, when compared to 
other professionals, there is a significant statistical 
difference. This data reinforces the importance of these 
professionals to update themselves correctly and to 
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It is know that the prophylactic use of medicines 
for a particular pathology needs to be scientifically 
evaluated, however, common sense can influence some 
people. In this study it was observed that health 
professionals and students had lower use of prophylactic 
form of Ivermectin for COVID-19 when compared to 
other professional classes (Table 3). Of the total 
number, 218 people claimed to have made use of 
Ivermectin prophylactically to treat Covid-19, which 
represents 48.2% of the sample and, of these, 64.2% 
had self-medication. This result may suggest that the 
information obtained correctly through scientific studies 
can decrease the indiscriminate use of some medicines. 
 
 








18-29 years old 170 37.4 
30-44 years old 152 33.4 
45-59 years old 101 22.2 
≥ 60 years old 32 7.0 
Sex 
  
Female 333 73.2 
Male 122 26.8 
Profession 
  
Health area 104 22.9 
Other areas  230 50.5 
Student 121 26.6 
Education level 
  
Complete/incomplete medical education 78 17.1 
Higher education 377 82.9 
Ethnicity   
White 360 79.1 
Black 7 1.5 
Brown 73 16.0 
Yellow 15 3.3 
 
 












Profession      
Health area 5.8 5.8 36.5 51.9 <0.001 
Other area 18.3 12.6 46.5 22.6  
Student 7.4 0.8 44.6 47.1  
 
Table 3. Prophylactic use of Ivermectin against Covid-19 compared to professions. 
Socio-demographic variables Used Ivermectin (%) Did not use Ivermectin prophylactically (%) p-value 
Profession   
0.002 
Health area 45.2 54.8 
Other area 55.7 44.3 




The study allow us to conclude that health 
professionals, as well as students, are more likely to 
search for information more correctly through scientific 
studies, which are more reliable sources. Therefore, this 
portion of the population made less prophylactic use of 
Ivermectin, which demonstrates that there is a relation 
between the information media used and the use of this 
drug. This enables us to conclude that the education and 
the professional axis have a strong influence on 
individual choices, being, hence, very much needed. 
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Thus, it is observed the imprescindibility of correct 
orientation in a massive way of the population to inform 
what are the best means of information to be used to 
promote the correct use of medicines. 
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